Vorasidenib
Drug timelines are a Plus or Pro feature.
18 regulatory and trial events tracked for Vorasidenib, covering 2023-11-24 to 2026-06-04. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 orIDH2 Mutation [Phase 3]